Approved Symbol |
Approved Name |
Source |
Evidence[PMID] |
ADAM17 |
ADAM metallopeptidase domain 17 |
Mapped by significant region |
IMP[18625725]
|
ERBB2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
Mapped by LD-proxy |
|
PLA2G6 |
phospholipase A2, group VI (cytosolic, calcium-independent) |
Mapped by PBA pathway |
|
FLT4 |
fms-related tyrosine kinase 4 |
Mapped by CNV |
IMP[11532940]
|
CDON |
Cdon homolog (mouse) |
Mapped by significant region |
|
DAB2 |
disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) |
Mapped by significant region |
IMP[12805222]
|
EDNRA |
endothelin receptor type A |
Mapped by PBA pathway |
|
MUSK |
muscle, skeletal, receptor tyrosine kinase |
Mapped by significant region |
|
MAPK3 |
mitogen-activated protein kinase 3 |
Mapped by CNV |
IMP[19664780]
|
KNDC1 |
kinase non-catalytic C-lobe domain (KIND) containing 1 |
Mapped by CNV |
|
MAPK9 |
mitogen-activated protein kinase 9 |
Mapped by CNV |
|
CCND1 |
cyclin D1 |
Mapped by significant region |
IDA[8114739]
|
FAM129A |
family with sequence similarity 129, member A |
Mapped by significant region |
|
SQSTM1 |
sequestosome 1 |
Mapped by CNV |
|
TBX1 |
T-box 1 |
Mapped by CNV |
|
CTGF |
connective tissue growth factor |
Mapped by significant region |
|
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
Mapped by significant region |
IDA[16055703]
|
IGF2 |
insulin-like growth factor 2 (somatomedin A) |
Mapped by LD-proxy; Mapped by literature SNP |
|
FLCN |
folliculin |
Mapped by significant region |
|
MAVS |
mitochondrial antiviral signaling protein |
Mapped by CNV |
IDA[16127453]
|
FGF4 |
fibroblast growth factor 4 |
Mapped by significant region |
|